Inventor · disambiguated record
Sreenivas Punna
Also filed as: PUNNA SREENIVAS
66 granted patents·9 pending applications·555 citations·filing 2006–2025
99Inventor score
Top patents by PatentIndex Score
75 records- 0199US7884110B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2008·Granted Feb 8, 2011·41 cites·6 claims
- 0298US11426364B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Aug 30, 2022·10 cites·6 claims
- 0398US7622583B2Heteroaryl sulfonamides and CCR2CHEMOCENTRYX INC·Filed 2006·Granted Nov 24, 2009·106 cites·5 claims
- 0497US11485708B2Compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Nov 1, 2022·9 cites·21 claims
- 0597US11266643B2Triaryl compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Mar 8, 2022·13 cites·32 claims
- 0697US11135210B2Indane-amines as PD-L1 antagonistsCHEMOCENTRYX INC·Filed 2020·Granted Oct 5, 2021·10 cites·23 claims
- 0797US10639284B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2017·Granted May 5, 2020·17 cites·30 claims
- 0897US9745312B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2016·Granted Aug 29, 2017·13 cites·19 claims
- 0996US11691985B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2021·Granted Jul 4, 2023·4 cites·20 claims
- 1096US11478460B2Diaryl substituted 6,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Oct 25, 2022·3 cites·34 claims
- 1196US11059834B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2019·Granted Jul 13, 2021·10 cites·18 claims
- 1296US10919852B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2018·Granted Feb 16, 2021·15 cites·25 claims
- 1396US10568874B2Indane-amines as PD-L1 antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Feb 25, 2020·13 cites·26 claims
- 1496US10562896B26-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Feb 18, 2020·11 cites·38 claims
- 1596US9394307B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2013·Granted Jul 19, 2016·15 cites·19 claims
- 1695US11708326B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Jul 25, 2023·4 cites·25 claims
- 1795US8546408B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationKRASINSKI ANTONI·Filed 2010·Granted Oct 1, 2013·23 cites·11 claims
- 1895US7718683B2Triazolyl phenyl benzenesulfonamidesCHEMOCENTRYX INC·Filed 2007·Granted May 18, 2010·39 cites·4 claims
- 1994US11142521B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Oct 12, 2021·4 cites·6 claims
- 2094US10683294B25-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Jun 16, 2020·8 cites·31 claims
- 2194US10329314B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2018·Granted Jun 25, 2019·12 cites·21 claims
- 2294US9745268B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Aug 29, 2017·11 cites·31 claims
- 2393US11479553B25-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Oct 25, 2022·3 cites·24 claims
- 2493US11384079B26-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2019·Granted Jul 12, 2022·5 cites·18 claims
- 2593US10828285B2Diaryl substituted 6,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Nov 10, 2020·5 cites·27 claims
- 2693US10392405B2Macrocyclic immunomodulatorsCHEMOCENTRYX INC·Filed 2018·Granted Aug 27, 2019·13 cites·46 claims
- 2793US10266492B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Apr 23, 2019·8 cites·10 claims
- 2892US11485737B2Diaryl substituted 5,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Nov 1, 2022·2 cites·29 claims
- 2992US8093247B2Heteroaryl sulfonamides and CCR2UNGASHE SOLOMON·Filed 2009·Granted Jan 10, 2012·18 cites·15 claims
- 3091US8445518B2Triazolyl pyridyl benzenesulfonamidesCHARVAT TREVOR T·Filed 2010·Granted May 21, 2013·21 cites·23 claims
- 3190US10759807B2Diaryl substituted 5,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Sep 1, 2020·7 cites·38 claims
- 3290US10487098B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Nov 26, 2019·6 cites·7 claims
- 3390US9758512B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2016·Granted Sep 12, 2017·6 cites·24 claims
- 3490US7776877B2N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamidesCHEMOCENTRYX INC·Filed 2008·Granted Aug 17, 2010·11 cites·6 claims
- 3589US10532982B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Jan 14, 2020·4 cites·1 claims
- 3688US8835419B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2012·Granted Sep 16, 2014·9 cites·30 claims
- 3787US10208050B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2017·Granted Feb 19, 2019·2 cites·18 claims
- 3887US9750722B2Diazole amidesCHEMOCENTRYX INC·Filed 2015·Granted Sep 5, 2017·5 cites·23 claims
- 3987US9567323B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2014·Granted Feb 14, 2017·6 cites·9 claims
- 4086US10407417B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Sep 10, 2019·3 cites·12 claims
- 4185US11254695B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Feb 22, 2022·1 cites·16 claims
- 4285US10744118B2Diazole lactamsCHEMOCENTRYX INC·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
- 4385US9169248B2Diazole amidesCHEMOCENTRYX INC·Filed 2013·Granted Oct 27, 2015·6 cites·22 claims
- 4484US7683176B2Triazolyl pyridyl benzenesulfonamidesCHEMOCENTRYX INC·Filed 2007·Granted Mar 23, 2010·7 cites·18 claims
- 4583US9328116B2Diazole lactamsCHEMOCENTRYX INC·Filed 2013·Granted May 3, 2016·4 cites·4 claims
- 4681US10206912B2Heteroaryl sulfonamides and CCR2/CCR9CHEMOCENTRYX INC·Filed 2016·Granted Feb 19, 2019·2 cites·26 claims
- 4779US11845729B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2022·Granted Dec 19, 2023·0 cites·10 claims
- 4878US11884654B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 4977US9409909B2N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamidesCHEMOCENTRYX INC·Filed 2014·Granted Aug 9, 2016·2 cites·14 claims
- 5077US8153818B2Triazolyl phenyl benzenesulfonamidesCHARVAT TREVOR T·Filed 2010·Granted Apr 10, 2012·3 cites·23 claims
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sreenivas Punna files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →